Chemical biotechnology: A happy marriage between chemistry and biotechnology: Asymmetric synthesis via green chemistry

Current Opinion in Biotechnology

Volumn 11, Issue 6, 2000, Pages 517-519

  Faber, Kurt ^a   Patel, Ramesh ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCATALYST; BIOTECHNOLOGY; BIOTRANSFORMATION; CHEMICAL BOND; CHIRALITY; DRUG INDUSTRY; ENANTIOMER; HYDROXYLATION; PRIORITY JOURNAL; REVIEW;

EID: 0033636716     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00157-9     Document Type: Editorial

References (12)

1. Stereoselective biotransformations in synthesis of some pharmaceutical intermediates
2. Microbial/enzymatic synthesis of chiral drug intermediates
3. Use of lipases in stereoselective catalysis
4. Biocatalytic transformation of racemates into chiral building blocks in 100% chemical yield and 100% enantiomeric excess
5. Enzymatic synthesis of L-6-hydroxynorleucine
6. Enzyme-mediated decarboxylation reactions in organic synthesis
7. Enzymatic asymmetric synthesis using aldolases
8. Continuous enzymatic transformation in an enzyme membrane reactor with simultaneous NAD(H) regeneration
9. Phenylalanine dehydrogenase catalyzed reductive amination of 6-(1'-2'-yl)-2-ketohexonoic acid to 6-(1',3'-dioxolan-2'-yl)-2S-aminohexanoic acid with NADH regeneration and enzyme cofactor retention